## **Core Concept**
Disseminated Intravascular Coagulation (DIC) is a serious disorder in which the proteins responsible for blood clotting become overactive, leading to widespread clot formation and bleeding. In the context of Acute Myeloid Leukemia (AML), certain subtypes are more commonly associated with DIC due to the release of pro-coagulant substances by the leukemic cells.

## **Why the Correct Answer is Right**
The correct answer, **M3 (Acute Promyelocytic Leukemia, APL)**, is particularly associated with DIC. APL cells release granules that contain pro-coagulant factors, tissue factor, and annexin A2, which can initiate the coagulation cascade and lead to DIC. This subtype of AML is uniquely characterized by a high risk of bleeding and thrombotic complications, making DIC a common and life-threatening complication.

## **Why Each Wrong Option is Incorrect**
- **Option A: M1**, This subtype of AML, also known as acute myeloblastic leukemia with minimal differentiation, does not have a specific association with DIC that is as pronounced as M3.
- **Option B: M2**, This subtype, acute myeloblastic leukemia with maturation, can have coagulopathy but is not as uniquely associated with DIC as M3.
- **Option D: M5**, This subtype, acute monocytic leukemia, has a lower incidence of DIC compared to M3.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **Acute Promyelocytic Leukemia (APL or M3)** is uniquely associated with **Disseminated Intravascular Coagulation (DIC)** and **all-trans retinoic acid (ATRA) therapy** is a cornerstone in its treatment, which can also help in managing the coagulopathy.

## **Correct Answer: C. M3.**